FBRX

13.55

128.69% 7.6249

Vorhandelsmarkt: 12.10 -1.45 -10.70%

Forte Biosciences Inc (FBRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$5.9251

Offen:

$10.46

24-Stunden-Volumen:

29.52M

Relative Volume:

64.32

Marktkapitalisierung:

$22.03M

Einnahmen:

Nettoeinkommen (Verlust:

$-31.48M

KGV:

-11.68

EPS:

-1.16

Netto-Cashflow:

$-28.71M

1W Leistung:

+138.98%

1M Leistung:

+186.47%

6M Leistung:

-10.72%

1J Leistung:

+11.16%

1-Tages-Spanne:

$8.7914

$18.81

1-Wochen-Bereich:

$5.3821

$18.81

52-Wochen-Spanne:

$4.11

$21.25

Forte Biosciences Inc Stock (FBRX) Company Profile

Firmenname

Forte Biosciences Inc

Sektor

Healthcare (1193)

Branche

Biotechnology (683)

Telefon

(310) 618-6994

Adresse

3060 PEGASUS PARK DRIVE, DALLAS, CA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

FBRX's Discussions on Twitter

Vergleichen Sie FBRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
FBRX	13.55	22.03M	0	-31.48M	-28.71M	-1.16
VRTX	451.23	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	743.35	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.82	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.79	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.14	24.49B	3.30B	-501.07M	1.03B	11.54

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-09-20	Hochstufung	Chardan Capital Markets	Sell → Buy
2021-09-03	Herabstufung	B. Riley Securities	Buy → Neutral
2021-09-03	Herabstufung	Chardan Capital Markets	Buy → Sell
2021-09-03	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2021-09-03	Herabstufung	Truist	Buy → Hold
2021-05-14	Eingeleitet	B. Riley Securities	Buy
2021-03-26	Eingeleitet	Citigroup	Buy
2020-08-28	Hochstufung	Chardan Capital Markets	Neutral → Buy
2020-08-25	Eingeleitet	Truist	Buy

Alle ansehen

Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten

Nov 20, 2024

Forte Biosciences secures $53 million in funding By Investing.com - Investing.com South Africa

Nov 20, 2024

Forte Biosciences Secures $53M for FB102 Advancements - TipRanks

Nov 20, 2024

Artelo Biosciences (ARTL) Stock Surges Amid Strong Buy Ratings - GuruFocus.com

Nov 20, 2024

Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com

Nov 20, 2024

Lexicon Pharmaceuticals (LXRX) Stock Plummets Amidst Market Acti - GuruFocus.com

Nov 20, 2024

Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild - Asianet Newsable

Nov 20, 2024

Stock Market News: Forte Biosciences +151.47%, Exicure +99.48% among top gainers during mid day trading - Business Upturn

Nov 20, 2024

Stock Market News: Ethan Allen Interiors down by 90.10% while Exicure gains 99.48% during mid day trading - Business Upturn

Nov 20, 2024

Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views - Benzinga

Nov 20, 2024

Stock Market Today: Forte Biosciences up by 54.60% while Red Cat Holdings gains 35% in early trading - Business Upturn

Nov 20, 2024

Stock Market Today: Ethan Allen Interiors falls by nearly 90% while Forte Biosciences surges by 64.89% in early trading - Business Upturn

Nov 20, 2024

US Stocks Mostly Lower; Target Posts Downbeat Earnings - Benzinga

Nov 20, 2024

Thrive Tribe Technologies Affirms ASX Compliance Amid Stock Query - MSN

Nov 20, 2024

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - The Bakersfield Californian

Nov 20, 2024

Forte Biosciences Secures $53M Private Placement for Autoimmune Drug Development | FBRX Stock News - StockTitan

Nov 20, 2024

IBD Rating Upgrades: Chesapeake Utilities Flashes Improved Relative Price Strength - MSN

Nov 20, 2024

Nov 19, 2024

Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - Lelezard

Nov 19, 2024

Forte Biosciences, Inc. announced that it expects to receive $53 million in funding from OrbiMed Advisors LLC, Janus Henderson Group plc, Tybourne Capital Management Limited, Ikarian Capital, LLC, BVF Partners L.P., Fred Alger Management, LLC - Marketscreener.com

Nov 19, 2024

When the Price of (FBRX) Talks, People Listen - Stock Traders Daily

Nov 19, 2024

Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN

Nov 19, 2024

Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Nov 19, 2024

Brown Advisory US Smaller Companies PLC Updates Office Location - MSN

Nov 19, 2024

Nov 18, 2024

Stephens & Co. Initiates Coverage of IDEAYA Biosciences (IDYA) with Overweight Recommendation - MSN

Nov 18, 2024

Nov 17, 2024

Forte Biosciences (NASDAQ:FBRX) Stock Price Expected to Rise, Chardan Capital Analyst Says - Defense World

Nov 17, 2024

Nov 15, 2024

Forte Biosciences Inc reports results for the quarter ended September 30Earnings Summary - XM

Nov 15, 2024

Perceptive Advisors LLC Acquires Shares in Forte Biosciences Inc - GuruFocus.com

Nov 15, 2024

Wolfe Research Initiates Coverage of Bristol-Myers Squibb CompanyPreferred Security (BMYMP) with Peer Perform Recommendation - MSN

Nov 15, 2024